The Oliver Law Group P.C. is Investigating Cases of Melanoma In Men Who Took Sildenafil (Viagra) After Study Finds Potential Link


New York NY (PRWEB) September 11, 2014

The Oliver Law Group P.C. reports that a recently published study has found that the use of Sildenafil citrate, sold as Viagra and Revatio increases the risk for developing melanoma skin cancer. Research published in the June 2014 issue of JAMA Internal Medicine showed men who said they used sildenafil, the generic name for Viagra, had an 84 percent risk for having invasive melanoma compared to men who did not use Viagra and other sildenafil drugs. According to researchers, the studys objective was to evaluate the link between sildenafil use and the melanoma risk among men in the United States. Researchers reviewed data from the Health Professionals Follow-up Study in which 25,848 men were questioned in 2000 about whether they use sildenafil for erectile dysfunction. The average age of the participants were about 65 years old. Researchers said they identified 142 melanoma cases, 580 squamous cell carcinoma cases and 3,030 cases of basal cell carcinoma during a follow-up from 2000 to 2010. Researchers observed that participants who took Sildenafil (Viagra) were at almost twice the risk for developing the dangerous skin cancer melanoma. Researchers noted that they supported a need for continual investigation into the association of Viagra with melonoma skin cancer, but did not observe an increase in risks associated with Viagra and other sildenafil drug use and the different types of skin cancers. [archinte.jamanetwork.com/article.aspx?articleid=1857095, June 2014]

In a commentary that accompanied the article, Dr. June K. Robinson, of the Department of Dermatology at Northwestern University Feinberg School of Medicine in Chicago, and editor of JAMA Dermatology, wrote that a prospective study with clearly defined criteria and known doses of sildenafil taken is needed before recommending changes in how men use sildenafil. According to Dr. Robinson, about 76,100 new melanomas will be diagnosed in 2014, and an estimated 9,710 men and women will die as a result of the diagnosis. However, patients in the very early stage of the disease have a 5-year survival rate of 99 percent when the cancer is treated with excision, according to Dr. Robinson. Those who are in Stage IIB, when the tumor has spread further into the lower part of the skin, have a 5-year survival rate of 57 percent. Dr. Robinson wrote that early detection of melanoma is needed and surgical excision of the cancer is critical. [archinte.jamanetwork.com/article.aspx?articleid=1857089, June 2014]

Viagra was approved in 1998 by the U.S. Food & Drug Administration as a prescription medication to treat erectile dysfunction in men. The drug became known as the blue pill because of its distinct blue color. Pfizer Inc., the maker of Viagra, and other manufacturers of drugs that treat erectile dysfunctio such as Cialis and Levitra, were told by the FDA in July 2005 to update there labels to include sudden vision loss as a side-effect of taking the drug. Two years later, the FDA required the drug manufacturers to display more prominently the potential risk for sudden hearing loss and what consumers should do if they experience hearing problems. Since hearing loss is associated with the aging process, the FDA suggested that some men who use Viagra may not think to talk to their doctor about it. Currently, the Viagra labeling includes other risks of side-effects, such as headache, upset stomach, back pain, muscle pain, nausea and dizziness. Priapism, an erection that will not go away, has also been reported by men who have taken the drug. It is recommended that men seek medical attention immediately if they experience this serious side-effect.

[fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108458.htm, July 8, 2005]

[fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109012.htm, October 18, 2007]

If You Believe You Have Developed Melanoma or Skin Cancer Due To Use of Viagra or other Sildenafil Medications Contact The Oliver Group P.C. To Learn More About Your Legal Options

The Oliver Law Group P.C. is a different kind of national law firm. One that focuses on the needs of the injured first. A compassionate law firm dedicated to fighting for the rights of victims and their families, and doing everything necessary to ensure those rights.

The experience of a large firm. The 1-on-1 dedication of a small firm. A reputation built on trust.

Experience. Dedication. Trust. Oliver Law Group P.C.

If you have developed melanoma skin cancer as a result of taking Sildenafil citrate, also known as Viagra, Revatio and under various other trade names,, turn to the law firm with the Experience, Dedication, and Trust you deserve. Contact the Oliver Law Group P.C. for your free Sildenafil melanoma skin cancer lawsuit case review by calling 1-800-939-7878 today or visit http://www.legalactionnow.com.







More Erectile Dysfunction Press Releases

European Urological Device Market Is Expected to Grow to over 2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus

Vancouver, BC (PRWEB) September 02, 2014

According to a new report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the European urological device market is expected to grow to over 2 billion in 2020. Growth will be fueled by an increase in the number of procedures for the treatment of BPH, nephrostomy, urinary and kidney stones. This market includes TURP devices, laser BPH devices, brachytherapy, urinary catheters, nephrostomy devices, urinary incontinence slings, stone treatment devices, urological endoscopes and erectile dysfunction devices.

Fastest growing market is urological endoscopes which comprise of cystoscopes for endoscopy of the urinary bladder, ureteroscopes for examining the ureter, resectoscopes used in transurethral resection of the prostate (TURP) and nephroscopes used to examine the kidneys. Growth in this market will be sustained by the range of procedures that require the use of urological endoscopes. It is estimated that over 1.6 million urological procedures will be performed in Europe by 2020.

Players driving the European urological device market are Coloplast, a prominent player in the markets for nephrostomy devices, urinary incontinence slings, stone treatment devices and erectile dysfunction devices as well as, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus.

Other key findings from the European Urological Device Market Report:

The number of TURP procedures continued to overshadow the number of laser BPH procedures in the treatment of benign prostate hyperplasia. The procedure is nearly as effective as open prostatectomy, but has a lower risk of serious complications such as blood loss, incontinence and impotence.

Growth of the brachytherapy market in Europe will vary by country, with some experiencing a contraction of the market and others experiencing an expansion. The largest percentage of brachytherapy procedures performed are in Germany. Procedures performed in France, the United Kingdom and Italy were also relatively large, although they all experienced moderate declines in procedural volumes.

The nephrostomy device market is dominated by the percutaneous nephrostomy set and balloon dilator segments. Sustained growth in these two segments will drive overall market expansion through 2020.

For Further Information

The global report series on the Markets for Urological Devices covers the U.S., Canada, 15 counties in Europe, Japan, India and China. The full reports provide a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players success strategies in each market and segment.

The reports cover devices used in the treatment of benign prostate hyperplasia (BPH), prostate cancer, and urinary incontinence as well as urinary and kidney stones. Other markets analyzed include urological endoscopes, urodynamic equipment and nephrostomy devices.

Get your free synopsis of the European urological device market report.

About iData Research

iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.







Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners


Parsippany, NJ (PRWEB) July 31, 2014

A cancer diagnosis is crushing and treatment is often harrowing. Yet millions of people survive cancer and resume normal lives. This is particularly true of prostate cancer which, according to the American Cancer Society, will affect one in seven American men but which when detected early, as 80% of prostate cancers are, has a five-year survival rate of nearly 100% and a ten-year survival rate of 99%. Prostate cancer is a serious illness but most men diagnosed with the disease do not die from it. There are 2.5 million men alive in the U.S. today who have been diagnosed with prostate cancer at some point in their lives.

After the ordeal of diagnosis and treatment, men and their partners look forward to life returning to normal, says clinical psychologist and relationship specialist Dr. Daniel Watter of Morris Psychological Group, and indeed it does in many respects. But most men treated for prostate cancer suffer a disruption in either libido or sexual function or both that may be temporary or may be long-lasting. It’s important for the couple to communicate openly with each other and with his medical team both before treatment to be prepared for possible side effects and after treatment to adjust to the physical and emotional impact on their relationship.

Most early-stage prostate cancers are treated in one of three ways: surgery to remove the prostate gland, radiation from an external beam, or radioactive seed implants. The choice of treatment is based on several factors including overall health, the size and location of the tumor, and consideration of the potential side effects of each option. While some sexual side effects are common with all treatments, surgery is most likely to cause long-lasting erectile dysfunction. That’s because the nerves responsible for an erection are very close to the prostate gland. Surgery often cuts them and radiation sometimes damages them. Depending on the location of the tumor, an approach called nerve-sparing surgery may reduce the risk and severity of post-surgical ED but doesn’t usually eliminate it entirely. Some men recover erectile function over a period of months or even years as nerve tissues heal and those who have had nerve-sparing surgery may regain function with the help of ED medications such as Viagra and Cialis. Other ED remedies, including penile rehabilitation, vacuum devices, and implants have varying degrees of success and side effects.

Erectile dysfunction and issues related to sexual intimacy can be challenging for couples in the best of circumstances, says Dr. Watter. In the midst of the anxiety and stress of a cancer diagnosis and choices to be made about treatment, sex may seem like the least important issue facing a couple. But those who face it early as treatment options are being weighed and with open, honest discussion from the outset, will have the most likelihood of successfully restoring sexual intimacy after treatment.

Tips for Patients and their Partners

Dr. Watter sees the restoration of intimacy as a process that will have successes and failures over time. He offers some advice to couples embarking on the journey:

Address the challenges as a couple: It should go without saying that loss of intimacy is not a problem only for the patient. His partner must be fully committed to the goal, must accept that things may not be the same as before, and must be willing to explore new options that redefine intimacy. Together they will learn that while their sex life may change, their relationship may ultimately be closer than before.
Be persistent…and keep your sense of humor: Don’t expect too much too soon. There will be disappointments. Not every option will work for every couple. For example, ED solutions like medication that improve blood flow do not work when the nerves have been cut. Other solutions may fail initially but ultimately be successful or vice versa.
Sexual satisfaction is possible without an erection: Vanquishing ED is not the only route to sexual satisfaction. Different nerves control erection and orgasm; even without an erection, orgasm is possible. And even without orgasm, emotional and physical intimacy can be maintained. Don’t let confusion or embarrassment prevent you from talking about the possibilities and seeking help.

The most important bit of advice is to keep the lines of communication open, even when especially when it is difficult, Dr. Watter concludes. Most men lead long, fulfilling lives after prostate cancer and have satisfying intimate relationships. As long as both partners are honest about their needs, they may find their relationship strengthened in ways they didn’t expect.

Daniel N. Watter, Ed.D. specializes in the treatment of individuals and couples experiencing sexual and/or relationship problems.

Morris Psychological Group, P.A. offers a wide range of therapy and evaluation services to adults, children and adolescents. http://www.morrispsych.com







Find More Erectile Dysfunction Medications Press Releases

Kama Raja – Natural Cure For Erectile Dysfunction

http://www.causesoferectiledysfunction.info Erectile dysfunction, a problem that most men are shy to admit or even want to talk about it. Basically, erectile…
Video Rating: 3 / 5

Medical animation created by KO Studios for Medtronic, Inc. showing the etiology of erectile dysfunction and its possible causes. Also, shows repair of low p…
Video Rating: 0 / 5

Erectile Dysfunction Treatment Prolargent 5×5 Extreme

” Prolargent5X5 Extreme is an excellent, easy-to-take it which is unique in that the treatment recommendations are individualized. upon taking one capsule an…

SHILAJIT wonder supplement. Boosts Vigor & Vitality http://rudramani.com As mentioned in Kamasutra http://rudramani.com Sexual dysfunction often refers to di…

Middle Aged Men Finding Success with Health Center’s Miami HRT Therapies


Miami, FL (PRWEB) August 28, 2014

Aging is a part of life. But thanks to the professionals at Elite Health Center, getting older doesnt have to define your lifestyle. Elite Health Center is Miamis premiere mens anti-aging clinic which utilizes the most new and innovative techniques of hormone replacement therapy to help men look and feel their best. The professionals at Elite Health Center evaluate each client to test their hormone levels and determine which course of Miami HRT is best suited for each individual. Based on the results, Elites physicians can construct a health protocol designed to boost hormone levels and help men look and feel years younger.

HRT has been proven to help men overcome a variety of age-related deficiencies including: